通过活动,营养和认知炼 (ENHANCE) 提高神经认知健康:一项随机对照试验
Li-Ning Peng1,2, Pei-Lin Lee2,3, Kun-Hsien Chou3,4
1Center for Geriatric and Gerontology, Taipei Veterans General Hospital, Taipei City, Taiwan.
Journal of cachexia, sarcopenia and muscle
|June 4, 2025
概括
一个为期12个月的多领域干预,促进健康的衰老,保留了大脑的灰质体积,并改善了老年人的身体和认知功能. 农村参与者表现出增强的大脑结构和认知收益,而城市参与者在体力表现方面表现出色.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
背景情况:
- 多领域干预措施对健康衰老有希望,但它们对大脑结构的影响尚不清楚.
- 该ENHANCE试验调查了为期12个月的基于小组的多领域干预,针对社区居住的老年人.
- 该研究特别研究了干预效应的城乡差异.
研究的目的:
- 评估多领域干预对老年人大脑结构和功能的有效性.
- 评估城市和农村参与者之间的干预结果差异.
- 探索干预对身体表现,认知和心脏代谢生物标志物的影响.
主要方法:
- 一个为期12个月的随机对照试验 (ENHANCE) 涉及每周两次的小组会议 (体育炼,认知训练,营养教育).
- 对照组每季度接受一次电话教育.
- 主要结局:脑灰质体积 (GMV) 通过MRI的基于voxel的变化;次要结局:身体表现,认知,营养,心理社会和心脏代谢标记.
主要成果:
- 与对照组相比,干预组在左下叶的GMV减少明显较小.
- 在干预组中观察到改善的身体表现和认知功能.
- 小组分析显示了差异效应:农村参与者保留了GMV和更大的认知改善,而城市参与者显示了更大的GMV减少,但身体表现更好.
结论:
- 多领域干预可以诱导老年人的神经可塑性.
- 干预对大脑结构和功能的影响在城市和农村人口之间有所不同.
- 需要考虑社会文化因素的定制方法,以优化不同人群的健康衰老.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.7K
06:09Wheel Running and Environmental Complexity as a Therapeutic Intervention in an Animal Model of FASD
Published on: February 2, 2017
6.7K
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
106
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Cognitive Development During Adulthood
65
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
65
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
